First pregnancy risk factors and future gestational diabetes mellitus

Israel Yoles1,2, Eyal Sheiner3, Tamar Wainstock4

  • 1Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel. yoles@netvision.net.il.

Insights

Complications in a first pregnancy, including hypertensive disorders, perinatal mortality, maternal obesity, and fetal macrosomia, significantly increase the risk of gestational diabetes mellitus (GDM) in a subsequent pregnancy. Early GDM detection is recommended for women with these prior complications.

Area of Science:

  • Obstetrics and Gynecology
  • Reproductive Health
  • Maternal-Fetal Medicine

Background:

  • Gestational diabetes mellitus (GDM) affects approximately 17% of pregnancies, posing risks to both mother and child.
  • Early diagnosis and intervention are crucial for mitigating adverse outcomes associated with GDM.

Purpose of the Study:

  • To identify characteristics from a first pregnancy that serve as risk factors for developing GDM in a subsequent pregnancy.
  • To inform targeted screening and management strategies for women at higher risk of GDM.

Main Methods:

  • A population-based nested case-control study involving women with two consecutive singleton pregnancies.
  • Comparison of first pregnancy characteristics and complications between women who developed GDM in their second pregnancy and those who did not.
  • Multivariable logistic regression analysis to assess the association between first pregnancy complications and subsequent GDM, adjusting for confounders.

Main Results:

  • 1.9% of 38,750 women developed GDM in their second pregnancy.
  • First pregnancy complications such as hypertensive disorders, perinatal mortality, maternal obesity, and fetal macrosomia were significantly associated with increased GDM risk in the second pregnancy.
  • The adjusted odds ratio for GDM increased by 2.33 with one complication and 5.38 with two or more complications from the first pregnancy.

Conclusions:

  • Specific first pregnancy complications are significant predictors of GDM in subsequent pregnancies.
  • Women experiencing hypertensive disorders, perinatal mortality, maternal obesity, or fetal macrosomia in their first pregnancy should be considered for early GDM screening in future pregnancies.
  • These findings support proactive monitoring and intervention for high-risk pregnancies to improve maternal and infant outcomes.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.9K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
420